Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) application for VNT-101, a novel direct-acting antiviral against Influenza A virus
/PRNewswire/ -- Via Nova Therapeutics, Inc., a biotechnology company focused on discovering and developing therapeutics to treat viral infections with...
Prnewswire Via Nova Therapeutics Inc Drug Administration Nova Therapeutics Investigational New Drug Don Ganem Via Nova
Source: prnewswire.com